Diversify Advisory Services »

Bioxcel Therapeutics shares owned by Diversify Advisory Services

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Diversify Advisory Services from 13F filings

Historical chart of Diversify Advisory Services investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Diversify Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Diversify Advisory Services

Quarter filed Position value Share count Share price at filing
2026-06-30 $13k 15k 0.87

More positions owned by Diversify Advisory Services

Ishares Tr Russell 2000 Etf (IWM)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Series Trust ST STR P500GRW (SPYG)
Apple (AAPL)
Spdr Series Trust St Str P500val (SPYV)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Motorola Solutions Com New (MSI)

View all positions for Diversify Advisory Services

Top funds holding Bioxcel Therapeutics

Millennium Management
Oaktree Capital Management
Vanguard Capital Management
Oaktree Fund Advisors
Geode Capital Management
BlackRock
UBS Group
Citadel Advisors
Vanguard Fiduciary Trust
State Street Corporation
FMR
Wiley Bros.-aintree Capital
Jones Financial Companies, L.L
Northern Trust
HighTower Advisors

View all funds holding Bioxcel Therapeutics